These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15275774)

  • 21. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
    Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
    Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
    St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
    Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
    Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
    Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of phosphorylated extracellular signal-regulated kinase in the mouse substance P pain model.
    Choi SS; Seo YJ; Kwon MS; Shim EJ; Lee JY; Ham YO; Park SH; Suh HW
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):152-8. PubMed ID: 15950773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal mechanisms of antinociceptive effect caused by oral administration of bis-selenide in mice.
    Jesse CR; Savegnago L; Nogueira CW
    Brain Res; 2008 Sep; 1231():25-33. PubMed ID: 18680735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
    Shimamura M; Shimizu M; Yagami T; Funabashi T; Kimura F; Kuroiwa Y; Misu Y; Goshima Y
    Neuropharmacology; 2006 Jun; 50(8):909-16. PubMed ID: 16504219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antinociceptive effects of ginsenosides injected intracerebroventricularly or intrathecally in substance P-induced pain model.
    Choi SS; Han EJ; Han KJ; Lee HK; Suh HW
    Planta Med; 2003 Nov; 69(11):1001-4. PubMed ID: 14735436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
    Lindgren HS; Rylander D; Ohlin KE; Lundblad M; Cenci MA
    Behav Brain Res; 2007 Feb; 177(1):150-9. PubMed ID: 17157933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice.
    Yu L; Schwarzschild MA; Chen JF
    Neurosci Lett; 2006 Jan; 393(1):31-5. PubMed ID: 16236444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
    Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
    Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K; Ferger B
    Neuroscience; 2009 Mar; 159(1):16-20. PubMed ID: 19146929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of alpha2-adrenoceptors in enhancement of antinociceptive effect in diabetic mice.
    Omiya Y; Yuzurihara M; Suzuki Y; Kase Y; Kono T
    Eur J Pharmacol; 2008 Sep; 592(1-3):62-6. PubMed ID: 18625215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice.
    Damaj MI; Hunter RG; Martin BR; Kuhar MJ
    Brain Res; 2004 Oct; 1024(1-2):146-9. PubMed ID: 15451376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of phosphorylation of calcium/calmodulin-dependent protein kinase-II in several brain regions by substance P administered intrathecally in mice.
    Choi SS; Seo YJ; Kwon MS; Shim EJ; Lee JY; Ham YO; Lee HK; Suh HW
    Brain Res Bull; 2005 May; 65(5):375-81. PubMed ID: 15833591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor mechanism(s) and antinociception and tolerance induced by swim stress in formalin test.
    Fazli-Tabaei S; Yahyavi SH; Nouri M; Zartab H; Javid G; Loghavi S; Zarrindast MR
    Behav Pharmacol; 2006 Jun; 17(4):341-7. PubMed ID: 16914952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
    Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
    Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2006 Mar; 1076(1):42-8. PubMed ID: 16476419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
    Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
    Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
    Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
    Glavan G; Zivin M
    Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.